Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of BIAsp 30 Regimens in T2D (SIT2MIX)
NCT01519674Phase 4Completed
- Sponsor
- Novo Nordisk
- Start
- Jun 2012
- Primary completion
- Oct 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 10
01
Overview
A Phase 4 trial of Insulin aspart + insulin aspart protamine in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Jun 2012; status: completed.
02
Drugs
Insulin aspart + insulin aspart protamine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01519674.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01519674.